Blocking specific macrophages leads to tumour shrinkage
A study has found that removing a particular kind of macrophage enables the immune system to attack tumours, providing a potential drug target.
List view / Grid view
A study has found that removing a particular kind of macrophage enables the immune system to attack tumours, providing a potential drug target.
A protein discovery could lead to a new and highly potent immune-therapeutic drug for the eradication of cancers using natural killer cells.
New findings suggest a possible new treatment strategy for severe dengue disease using the tryptase inhibitor, nafamostat mesylate.
Using new technology researchers have shown that sick mitochondria pollute the cells they are supposed to be supplying with power.
Researchers have created a new technique for activating genes using bacteria which could have therapeutic uses.
Scientists have shown that there are molecules to remodel the gut microbiome and turn an unhealthful gut into a more healthful one for the first time.
MSD and the Francis Crick Institute will work together on a project to identify disease targets for motor neuron disease.
Researchers have discovered the roles that immune cells play in tumour growth and breast cancer immunotherapy which could aid in drug development.
A tumour-targeted CRISPR gene editing system encapsulated in a nanogel could halt the growth of triple-negative breast cancer.
A ‘bronchi-on-a-chip’ has been created by researchers to identify the processes of bronchospasms which could aid in respiratory disease therapies.
Researchers have discovered that MYC cancers use the cell’s machinery to make lipids and identified a lipid signature, which could be exploited in the development of new therapies.
Researchers have created a new organoid model that can be used to study systems such as the heart and the effects of drugs on these cells.
Researchers have discovered the mechanism behind the viral genome for measles, which could serve as a druggable target.
New computer model that simulates the way red blood cells become misshapen by sickle cell disease could identity promising drug candidates.
Targeting a deadly bacteria's use of succinate in the lungs could control infection and improve the health of people with cystic fibrosis.